Stay updated on Anti-CD137 and Anti-CTLA-4 combo Clinical Trial.

Sign up to get notified when there's something new on the Anti-CD137 and Anti-CTLA-4 combo Clinical Trial. page.
Latest website image capture
Clouds background image

Latest updates to the Anti-CD137 and Anti-CTLA-4 combo Clinical Trial. page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s revision/version label has been updated from v3.5.2 to v3.5.3 in the site footer, indicating a minor site release rather than a change to the trial record content.
    Difference
    0.1%
    Check dated 2026-04-24T05:48:06.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Version history updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:05:44.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Added version v3.5.0 to the history. Removed version v3.4.3 from the history.
    Difference
    0.1%
    Check dated 2026-03-18T21:17:48.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision history shows the addition of v3.4.3 and removal of v3.4.2 from the history.
    Difference
    0.1%
    Check dated 2026-03-11T18:20:31.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The history now includes Revision: v3.4.2 and removes the prior funding-status notice; this is a maintenance/version update with no changes to trial data.
    Difference
    0.7%
    Check dated 2026-02-11T11:18:34.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    A site-wide notice about government funding and operating status appears. The page also shows a revision banner indicating v3.4.1, replacing v3.4.0.
    Difference
    0.7%
    Check dated 2026-02-04T06:47:00.000Z thumbnail image

Stay in the know with updates to Anti-CD137 and Anti-CTLA-4 combo Clinical Trial.

Enter your email address, and we'll notify you when there's something new on the Anti-CD137 and Anti-CTLA-4 combo Clinical Trial. page.